Back
Reshape Lifesciences Quote, Financials, Valuation and Earnings
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
34
RSLS
Reshape Lifesciences
Last Price:
0.16
Seasonality Move:
-15.67%
7 Day Trial
ALL ACCESS PASS
$
7
Former Chicago Pit Trader Exposes Shocking Trading Advantage:
See How to Target Up to 383% OVERNIGHTReshape Lifesciences Price Quote
$0.16
-0.01 (-4.65%)
(Updated: September 16, 2024 at 2:50 PM ET)
Reshape Lifesciences Key Stats
Sell
34
Reshape Lifesciences (RSLS)
is a Sell
Day range:
$0.16 - $0.17
52-week range:
$0.14 - $0.79
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.39
P/B ratio:
1.62%
Volume:
239.3K
Avg. volume:
382.1K
1-year change:
-77.92%
Market cap:
$4.9M
Revenue:
$8.7M
EPS:
$-1.24
How Much Does Reshape Lifesciences Make?
-
How Much Are Reshape Lifesciences's Sales Annually?
RSLS Revenues are $8.7M -
How Much Profit Does Reshape Lifesciences's Make A Year?
RSLS net income is -$11.4M
Is Reshape Lifesciences Growing As A Company?
-
What Is Reshape Lifesciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.13% -
What Is Reshape Lifesciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Reshape Lifesciences Stock Price Performance
-
Did Reshape Lifesciences Stock Go Up Last Month?
Reshape Lifesciences share price went down by -3.51% last month -
Did RSLS's Share Price Rise Over The Last Year?
RSLS share price fell by -77.92% over the past 1 year
What Is Reshape Lifesciences 52-Week High & Low?
-
What Is Reshape Lifesciences’s 52-Week High Share Price?
Reshape Lifesciences has traded as high as $0.79 over the past 52 weeks -
What Is Reshape Lifesciences’s 52-Week Low Share Price?
Reshape Lifesciences has traded as low as $0.14 over the past 52 weeks
Reshape Lifesciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Reshape Lifesciences?
-
How Much Debt Does Reshape Lifesciences Have?
Total long term debt quarterly is $0 -
How Much Cash Does Reshape Lifesciences Have?
Cash and short term investments quarterly total is $1.1M -
What Is Reshape Lifesciences’s Book Value Per Share?
Book value per share is 0.10
Is Reshape Lifesciences Cash Flow Positive?
-
What Is RSLS Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.7M -
What Is Reshape Lifesciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.1M -
What Is Reshape Lifesciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Reshape Lifesciences Return On Invested Capital
-
Is Management Doing A Good Job?
RSLS return on invested capital is -187.5% -
What Is Reshape Lifesciences Return On Assets?
ROA measures how assets are converting to revenues and is -100.3% -
What Is RSLS Return On Equity?
ROE is a measure of profitability and is -187.5%
Reshape Lifesciences Earnings Date & Stock Price
-
What Is Reshape Lifesciences's Stock Price Today?
A single share of RSLS can be purchased today for 0.17 -
What Is Reshape Lifesciences’s Stock Symbol?
Reshape Lifesciences trades on the nasdaq under the ticker symbol: RSLS -
When Is Reshape Lifesciences’s Next Earnings Date?
The next quarterly earnings date for Reshape Lifesciences is scheduled on November 8, 2024 -
When Is RSLS's next ex-dividend date?
Reshape Lifesciences's next ex-dividend date is September 16, 2024 -
How To Buy Reshape Lifesciences Stock?
You can buy Reshape Lifesciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Reshape Lifesciences Competitors
-
Who Are Reshape Lifesciences's Competitors?
Below is a list of companies who compete with Reshape Lifesciences or are related in some way:
Reshape Lifesciences Dividend Yield
-
What Is RSLS Dividend Yield?
Reshape Lifesciences’s dividend yield currently is 0% -
What Is Reshape Lifesciences’s Payout Ratio?
Reshape Lifesciences’s payout ratio is 0% -
When Did Reshape Lifesciences Last Pay A Dividend?
The latest dividend pay date is September 16, 2024 -
What Is Reshape Lifesciences’s Dividend Per Share?
Reshape Lifesciences pays a dividend of $0.00 per share
Reshape Lifesciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 41% |
| Revenue: | -12.82% | -7.61% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 1.00 |
| Upside from Last Price: | 495.95% |